Nanomedicine News

RSS

Scientists Develop Nanocarriers Capable of Transporting Medicines Specifically to Disease Site

Nanoparticles are extremely small particles that can be modified for a variety of uses in the medical field. For example, nanoparticles can be engineered to be able to transport medicines specifically to the disease site while not interfering with healthy body parts.

6 Mar 2015

Cerulean and GOG Foundation Partner to Conduct CRLX101-Paclitaxel Combination Clinical Trial for Relapsed Ovarian Cancer

Cerulean Pharma Inc., a leader in Dynamic Tumor Targeting™, today announced it has signed a clinical research agreement with the GOG Foundation Inc. to conduct an open-label Phase 1b clinical trial of its lead product candidate, CRLX101, in combination with weekly paclitaxel in patients with relapsed ovarian cancer.

4 Mar 2015

Next-Generation Magnetic Nanoparticles to Treat Deep-Seated Tumors

Thanks to the work of an interdisciplinary team of researchers at the Dartmouth Center of Nanotechnology Excellence, funded by the National Institutes of Health, the next-generation magnetic nanoparticles (MNPs) may soon be treating deep-seated and difficult-to-reach tumors within the human body.

4 Mar 2015

Novel Nanodevice Blocks Drug-Resistant Genes and Then Releases Cancer Drugs

Chemotherapy often shrinks tumors at first, but as cancer cells become resistant to drug treatment, tumors can grow back. A new nanodevice developed by MIT researchers can help overcome that by first blocking the gene that confers drug resistance, then launching a new chemotherapy attack against the disarmed tumors.

From Massachusetts Institute of Technology 3 Mar 2015

EC Approves Celgene’s ABRAXANE for First-Line Treatment of Non-Small Cell Lung Cancer

Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation, today announced that the European Commission (EC) has approved ABRAXANE® (paclitaxel formulated as albumin-bound nanoparticles, or nab-paclitaxel) in combination with carboplatin for the first-line treatment of non-small cell lung cancer in adult patients who are not candidates for potentially curative surgery and/or radiation therapy.

3 Mar 2015

New Insight Report on Cancer Nanomedicine Market

Research and Markets has announced the addition of the "Cancer Nanomedicine Market & Pipeline Insight 2015" report to their offering.

26 Feb 2015

University of Manchester Scientists Selectively Target and Neutralize Cancer Stem Cells Using Graphene

University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells.

26 Feb 2015

Innovative Approach Combines Nanotechnology and Molecular Biology to Tackle Brain Cancer

There are no effective available treatments for sufferers of Glioblastoma multiforme (GBM), the most aggressive and devastating form of brain tumor. The disease, always fatal, has a survival rate of only 6-18 months.

25 Feb 2015

UCLA Researchers Devise Optimized Nanodrug Combination Approach

In greater than 90 percent of cases in which treatment for metastatic cancer fails, the reason is that the cancer is resistant to the drugs being used. To treat drug-resistant tumors, doctors typically use multiple drugs simultaneously, a practice called combination therapy. And one of their greatest challenges is determining which ratio and combination -- from the large number of medications available -- is best for each individual patient.

From University of California, Los Angeles 25 Feb 2015

Rapid Diagnostic Test for Ebola and Other Fevers Using Multicolored Nanoparticles

When diagnosing a case of Ebola, time is of the essence. However, existing diagnostic tests take at least a day or two to yield results, preventing health care workers from quickly determining whether a patient needs immediate treatment and isolation.

24 Feb 2015

Nanomedicine News

Scientists Develop Nanocarriers Capable of Transporting Medicines Specifically to Disease Site

Cerulean and GOG Foundation Partner to Conduct CRLX101-Paclitaxel Combination Clinical Trial for Relapsed Ovarian Cancer

Next-Generation Magnetic Nanoparticles to Treat Deep-Seated Tumors

Novel Nanodevice Blocks Drug-Resistant Genes and Then Releases Cancer Drugs

EC Approves Celgene’s ABRAXANE for First-Line Treatment of Non-Small Cell Lung Cancer

New Insight Report on Cancer Nanomedicine Market

University of Manchester Scientists Selectively Target and Neutralize Cancer Stem Cells Using Graphene

Innovative Approach Combines Nanotechnology and Molecular Biology to Tackle Brain Cancer

UCLA Researchers Devise Optimized Nanodrug Combination Approach

Rapid Diagnostic Test for Ebola and Other Fevers Using Multicolored Nanoparticles

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials